Probe | Locus(GRCh37) | Gene | Region | p-val | Trait | PubMed ID |
cg24325790 | chr17:34345392 | CCL23 | Promoter | 5.388e-4 | Alcohol use disorders | 26763658 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
FAM129A | 0.587 |
MAP7D3 | 0.551 |
IQGAP2 | 0.547 |
TREML4 | 0.541 |
COL3A1 | 0.53 |
ECSCR | 0.524 |
NCF2 | 0.523 |
PLBD1 | 0.517 |
MYOF | 0.516 |
MNDA | 0.513 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
NEUROG2 | -0.309 |
C19orf73 | -0.307 |
ASPDH | -0.301 |
ATP2C2 | -0.293 |
HAGHL | -0.286 |
MAGIX | -0.284 |
HYAL3 | -0.281 |
CHRNA4 | -0.277 |
MFSD3 | -0.274 |
GAL3ST3 | -0.273 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of CCL23 mRNA | 24449571 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CCL23 mRNA | 15761015 |
C006780 | bisphenol A | bisphenol A results in decreased expression of CCL23 mRNA | 28079927 |
D017332 | Cetirizine | [Cetirizine co-treated with Dietary Fats co-treated with APOE gene mutant form] results in decreased expression of CCL23 protein | 25020133 |
D002945 | Cisplatin | Cisplatin results in increased expression of CCL23 mRNA | 27594783 |
D004041 | Dietary Fats | [Cetirizine co-treated with Dietary Fats co-treated with APOE gene mutant form] results in decreased expression of CCL23 protein | 25020133 |
C433788 | lipopolysaccharide, E. coli O26-B6 | "lipopolysaccharide, E. coli O26-B6 results in decreased expression of CCL23 mRNA" | 23090859 |
D017258 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate results in increased expression of CCL23 mRNA | 20843944 |
C088658 | zoledronic acid | zoledronic acid results in increased expression of CCL23 mRNA | 24714768 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0008009 | chemokine activity | - | IBA | 21873635 |
GO:0008009 | chemokine activity | - | IDA | 10660125 |
GO:0008201 | heparin binding | - | IEA | - |
GO:0031726 | CCR1 chemokine receptor binding | - | IPI | 10660125 |
GO:0048020 | CCR chemokine receptor binding | - | IBA | 21873635 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0002548 | monocyte chemotaxis | - | IBA | 21873635 |
GO:0002548 | monocyte chemotaxis | - | IC | 10660125 |
GO:0006874 | cellular calcium ion homeostasis | - | TAS | 9886417 |
GO:0006935 | chemotaxis | - | TAS | 9104803 |
GO:0006954 | inflammatory response | - | IBA | 21873635 |
GO:0006955 | immune response | - | TAS | 9104803 |
GO:0007165 | signal transduction | - | NAS | 9886417 |
GO:0007186 | G-protein coupled receptor signaling pathway | - | IBA | 21873635 |
GO:0007186 | G-protein coupled receptor signaling pathway | - | TAS | - |
GO:0007267 | cell-cell signaling | - | TAS | 9104803 |
GO:0008285 | negative regulation of cell proliferation | - | TAS | 9104803 |
GO:0010469 | regulation of signaling receptor activity | - | IEA | - |
GO:0030593 | neutrophil chemotaxis | - | IBA | 21873635 |
GO:0043547 | positive regulation of GTPase activity | - | IBA | 21873635 |
GO:0048245 | eosinophil chemotaxis | - | IBA | 21873635 |
GO:0048247 | lymphocyte chemotaxis | - | IBA | 21873635 |
GO:0050729 | positive regulation of inflammatory response | - | IBA | 21873635 |
GO:0070098 | chemokine-mediated signaling pathway | - | IBA | 21873635 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | - | IBA | 21873635 |
GO:0071346 | cellular response to interferon-gamma | - | IBA | 21873635 |
GO:0071347 | cellular response to interleukin-1 | - | IBA | 21873635 |
GO:0071356 | cellular response to tumor necrosis factor | - | IBA | 21873635 |
GO:2001264 | negative regulation of C-C chemokine binding | - | IDA | 10660125 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005576 | extracellular region | - | TAS | - |
GO:0005615 | extracellular space | - | IBA | 21873635 |
GO:0005623 | cell | - | IEA | - |
KEGG ID | KEGG Term |
---|---|
hsa04060 | Cytokine-cytokine receptor interaction |
hsa04062 | Chemokine signaling pathway |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-162582 | Signal Transduction | TAS |
R-HSA-372790 | Signaling by GPCR | TAS |
R-HSA-373076 | Class A/1 (Rhodopsin-like receptors) | TAS |
R-HSA-375276 | Peptide ligand-binding receptors | TAS |
R-HSA-388396 | GPCR downstream signalling | TAS |
R-HSA-416476 | G alpha (q) signalling events | TAS |
R-HSA-418594 | G alpha (i) signalling events | TAS |
R-HSA-444473 | Formyl peptide receptors bind formyl peptides and many other ligands | TAS |
R-HSA-500792 | GPCR ligand binding | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
29616282 | A large lung gene expression study identifying IL1B as a novel player in airway inflammation in COPD airway epithelial cells. (2018 Jun) | Yi G | Inflamm Res |